Portfolio company
GIVAX
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops oral mucosal vaccines to protect children and adults against gastrointestinal diseases like rotavirus and norovirus.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
GlycoVaxyn
This biotechnology company develops bioconjugate vaccines for pharmaceutical partners to prevent and treat bacterial infections.
Mivac Development
This biopharmaceutical company develops mucosal vaccines and treatments for autoimmune diseases for the global healthcare and pharmaceutical industries.
Tolergyx
This company develops gastrointestinal immunotherapy capsules to treat food allergies in pediatric and adult patients.
Astrivax
This biopharmaceutical company develops thermostable vaccines and immunotherapies to prevent or treat infectious diseases and virus-driven cancers for patients worldwide.
TEORA
This company develops orally delivered vaccines and biologics for aquaculture, livestock and agriculture customers to prevent diseases and enhance growth.
MinervaX
This biotechnology company develops a protein-based vaccine against Group B Streptococcus for pregnant women, newborns, and older adults.
Centivax
This company develops broad-spectrum vaccines and monoclonal antibodies using computational immune engineering to protect against infectious diseases and pathogens for global healthcare systems.
Human Biome
This biotechnology firm develops gut microbiota-based biotherapeutics and fecal microbiota transplantation preparations for medical professionals treating gastrointestinal infections and antibiotic resistance.
